Cost-effectiveness analysis of toripalimab plus chemotherapy as the first-line treatment in patients with advanced non-small cell lung cancer (NSCLC) without EGFR or ALK driver mutations from the…

Overview of attention for article published in Frontiers in Pharmacology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in BMC Cancer (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.